Automated synthesis of gene fragments using the BioXp™ system enables overnight production of error-corrected, de novo synthetic genes of up to 7,200 base pairs in length San Diego, CA – Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the addition of longer fragment […]

Genomics innovator steps up to accelerate groundbreaking platform SAN DIEGO — Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, announces the promotion of Richard Shen, PhD to the role of President. Richard brings over 20 years of leadership experience from the Next Generation Sequencing (NGS) and molecular diagnostic markets. Richard […]

BOULDER, Colo. — Watchmaker Genomics, a life science tools company that specializes in high-performance genomics application development, and Molecular Loop, an industry-leader in molecular inversion probe (MIP)-based assays, have announced a collaboration to accelerate the commercialization of streamlined, high-stringency genetic testing for pathogen surveillance. Watchmaker brings deep domain expertise in computational biology, high-throughput enzyme engineering, and large-scale enzyme production […]

SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that the Georgia Esoteric and Molecular (GEM) Laboratory at the Medical College of Georgia (MCG) at Augusta University is now offering diagnostic services for constitutional genetic disorders through a laboratory-developed test (LDT) based on optical genome mapping (OGM) with the Saphyr® System. The LDT developed […]

SAN DIEGO —  Illumina, Inc. (NASDAQ: ILMN) announced today that it has filed an action in the General Court of the European Union asking for annulment of the European Commission’s decision asserting jurisdiction to review Illumina’s acquisition of GRAIL. The Commission asserted jurisdiction to review the acquisition under Article 22 of the EU Merger Regulation […]

Welcomes Vice President of Research and Development, Vice President of Marketing and Vice President of Sales to fuel innovation and growth SAN DIEGO, Calif. —  Jumpcode Genomics, a genome technology platform company focused on enabling genomic analysis, today announced the appointment of three new key hires to its growing team. Jon Armstrong joins the company […]

Pioneering next-level sample processing with connectivity, simplicity, and unmatched flexibility Building on the success of EZ1 technology, three versions offer application area tailored value Integration with QIAsphere digital infrastructure allows for optimized lab productivity GERMANTOWN, Md. & HILDEN, Germany — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the upcoming launch of the […]

Supporting families of children with developmental differences SEATTLE and GAITHERSBURG, MD. – The University of Washington’s School of Medicine Brotman Baty Institute for Precision Medicine is collaborating with Illumina, Inc. (Nasdaq: ILMN) and GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company, to study early detection of developmental differences in […]

SAN DIEGO –Illumina, Inc. (NASDAQ: ILMN) has committed US $60 million in sequencing capabilities to a global pathogen genomics initiative, in partnership with the Bill & Melinda Gates Foundation and other public and private entities. The initiative expands on the Africa Pathogen Genomics Initiative (Africa PGI) announced in October 2020, and will help create a […]

SOUTH SAN FRANCISCO, Calif. & FRANKFURT — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Vivlion GmbH, a company providing next-generation CRISPR gRNA libraries and screening services for the global R&D market, today announced a collaboration for the generation of […]